A Model Citizen? Is Tamoxifen More Effective Than Aromatase Inhibitors if We Pick the Right Patients?

相似書籍

• Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?
  由: Stearns, Vered, et al.
  出版: (2008)
• CYP2D6 genotype and tamoxifen response
  由: Rae, James M, et al.
  出版: (2005)
• Patient-Reported Symptoms and Discontinuation of Adjuvant Aromatase Inhibitor Therapy
  由: Kidwell, Kelley M., et al.
  出版: (2014)
• Genetic Associations With Toxicity-related Discontinuation of Aromatase Inhibitor Therapy for Breast Cancer
  由: Henry, N. Lynn, et al.
  出版: (2013)
• Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management
  由: Gaillard, Stéphanie, et al.
  出版: (2011)